Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
1.170
+0.090 (8.33%)
Sep 8, 2025, 4:00 PM - Market closed

Oragenics Statistics

Total Valuation

Oragenics has a market cap or net worth of $4.83 million. The enterprise value is $5.73 million.

Market Cap4.83M
Enterprise Value 5.73M

Important Dates

The last earnings date was Friday, August 8, 2025, after market close.

Earnings Date Aug 8, 2025
Ex-Dividend Date n/a

Share Statistics

Oragenics has 4.13 million shares outstanding. The number of shares has increased by 355.75% in one year.

Current Share Class 4.13M
Shares Outstanding 4.13M
Shares Change (YoY) +355.75%
Shares Change (QoQ) +20.53%
Owned by Insiders (%) 0.41%
Owned by Institutions (%) 3.28%
Float 4.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.50

Current Ratio 0.50
Quick Ratio 0.46
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.03

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -245.73%
Return on Invested Capital (ROIC) -541.98%
Return on Capital Employed (ROCE) 448.05%
Revenue Per Employee n/a
Profits Per Employee -$2.06M
Employee Count5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.43% in the last 52 weeks. The beta is 0.82, so Oragenics's price volatility has been lower than the market average.

Beta (5Y) 0.82
52-Week Price Change -92.43%
50-Day Moving Average 1.37
200-Day Moving Average 6.00
Relative Strength Index (RSI) 44.12
Average Volume (20 Days) 100,971

Short Selling Information

The latest short interest is 18,730, so 0.45% of the outstanding shares have been sold short.

Short Interest 18,730
Short Previous Month 68,033
Short % of Shares Out 0.45%
Short % of Float 0.47%
Short Ratio (days to cover) 0.09

Income Statement

Revenue n/a
Gross Profit -3.34M
Operating Income -9.53M
Pretax Income -19.52M
Net Income -10.30M
EBITDA n/a
EBIT -9.53M
Earnings Per Share (EPS) -$20.91
Full Income Statement

Balance Sheet

The company has $1.97 million in cash and $3.00 million in debt, giving a net cash position of -$1.03 million or -$0.25 per share.

Cash & Cash Equivalents 1.97M
Total Debt 3.00M
Net Cash -1.03M
Net Cash Per Share -$0.25
Equity (Book Value) -2.13M
Book Value Per Share -2.59
Working Capital -2.13M
Full Balance Sheet

Cash Flow

Operating Cash Flow -7.42M
Capital Expenditures n/a
Free Cash Flow -7.42M
FCF Per Share -$1.80
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Oragenics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -355.75%
Shareholder Yield -355.75%
Earnings Yield -218.94%
FCF Yield -157.60%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on June 3, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date Jun 3, 2025
Split Type Reverse
Split Ratio 1:30

Scores

Altman Z-Score n/a
Piotroski F-Score 1